Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on the acute migraine drugs market provides an in-depth
analysis of segments and sub-segments in the global as well as regional acute
migraine drugs market. The study also highlights the impact of drivers, restraints,
and macro indicators on the global and regional acute migraine drugs market
over the short term as well as the long term. The report is a comprehensive
presentation of trends, forecasts and dollar values of the global acute migraine
drugs market. According to the report, the global acute migraine drugs market
is projected to grow at a CAGR of about 7% over the forecast period of
2022-2028.
The revenue generated by the global
acute migraine drugs market was over USD 2100 million in 2022 and is expected
to reach nearly USD 3200 million in 2028 and is expected to grow with a CAGR of
about 7% over the forecast period 2022-2028. The global acute migraine drugs
market exhibited strong growth during the forecast period. Migraine is known a
neurological condition that causes unilateral or throbbing pain within the
forehead, side of the pinnacle, or beside the eyes. The pain is usually because
of autonomic symptoms, like nausea, vomiting, photophobia, and phonophobia. Acute
migraine is usually diagnosed by examining the patient’s medical record and
symptoms, further as by performing blood tests, resonance imaging, and
computerized axial tomography scans. A major rise in the prevalence and
diagnosis of acute migraine represents one of the key factors bolstering market growth. Other than this, the development of reimbursement policies for
acute migraine medications, together with the escalating demand for precision
medicines, is additionally contributing to the market growth. Furthermore, the
rising demand for electrical nerve stimulating devices to treat acute migraine
and therefore the projected approval of recent classes of medication that are
within the late-stage pipeline and have higher clinical efficacy, like the
introduction of calcitonin gene-related peptide monoclonal antibodies, are
boosting the market growth. The testing of acute migraine drugs for the
treatment of coronavirus disease is anticipated to form a positive impact on
the market growth.
The rising population worldwide,
and therefore the growing demand for quality drugs are significant factors
driving the expansion of the worldwide acute migraine drugs market. The
prevalence of this disease is higher in women. Therefore, the growing female
population worldwide could be a big plus to the worldwide acute migraine drugs
market expansion. Additionally, factors like increasing work pressure, high
alcohol consumption, growing demand for quality drugs, changes in lifestyles,
and awareness among patients related to the prevention and treatment of
migraine further increase the demand levels for the world acute migraine drugs
market. Side effects that connect with migraine drugs are hampering the
expansion of the market, additionally, stringent rules and regulations by the
govt are hindering the expansion rate of the acute migraine drugs market. Also,
drugs' harmful effects and therefore the increasing precedence of other
therapies restrain the expansion during the forecast period.
Migraine is
one of the medical conditions of headache Many COVID-19 patients who had
recovered have reported that they felt a headache-like migraine during the
quarantine period. The sudden outbreak of COVID-19 has increased stress levels
by a considerable amount of the globe. This reflection on the global
increase of individuals plagued by migraines. The marketplace for migraine
drugs has seen a spike in demand since the start of the COVID-19 pandemic.
Growing sales of triptans demanded by consumers with acute migraine conditions
have boosted the market growth. It's predicted that, with the support received
from COVID-19, the worldwide acute migraine drugs market will register new growth
heights during the forecast period.
Among the regions, North America
holds the biggest market share of the acute migraine drugs market. The
increasing number of patients, growing investments in R&D activities, and
the establishment of technically advanced research centers will contribute to
the acute migraine drugs market growth in the region. However, the Asia Pacific
is expected to perform the fastest growth in the acute migraine drugs market.
The rise in focus of vendors on emerging markets, such as Asia-Pacific and
LAMEA, is expected to boost the market growth. Asia-Pacific is anticipated to
observe major growth in the forecast period, due to increasing demand for
better healthcare facilities and rising healthcare infrastructure. Furthermore,
this region presents remarkable opportunities for venture capitalists and
investors, as the developed markets are comparatively saturated.
The report on the global acute
migraine drugs market covers segments such as drug, application, and
distribution channel. On the basis of drug, the sub-markets include abortive
medicine, and preventive medicine. On the basis of application, the sub-markets
include oral, injectable, and nasal sprays. On the basis of distribution
channel, the sub-markets include hospital-based pharmacies, retail pharmacies,
and online pharmacies.
The report provides profiles of
the companies in the market such as Endo Pharmaceuticals Inc, Allergan, Impax
Laboratories, Glaxo Smith Kline plc, Astellas Pharma Inc., Amgen, Bayer,
AstraZeneca, Dr. Reddy’s Laboratories, and Zogenix.
The report provides deep insights
into demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the acute migraine drugs market. Moreover, the study highlights current
market trends and provides forecasts from 2022-2028. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players.
Please Choose One of them.